Yaz - More to the Story
People often wonder if their input into a major case like the numerous lawsuits versus Yaz and Yasmin will matter. This kind of hesitation is a result of not understanding just how powerful the cumulative effect of many stories can be. Yes, it is often the bigger stories — such as that of a young Broadway actress taking Yaz and suffering an unexpected stroke — that gain the most press. However, no celebrity can be so famous as to single-handedly force a company into accountability. That task lies with the many people who are consistently willing to come forward and give their stories concerning the matter.
Illustrating the power of cooperative effect, consider that it has been approximately two years since Yaz was advertised with a popular balloon metaphor commercial, where the balloons were marked with words such as “irritability” and the like. The comments section on the video, which is up on YouTube, is rife with commentary about personal bad experiences with the medicine. These include comments from women who heard bad press and are staying away from the contraceptive, as well as women who describe painful gallbladder problems and surgeries that were necessary after they took the medicine.
Yaz' manufacturers were cited for a failure to provide patients with sufficient information about the risks of this drug, and are being required to elaborate on the potential dangers of blood clots, heart complications, stroke and gallbladder damage that may result from extended exposure to the medicine. As of the time of this writing, more than 1,000 lawsuits are pending against Yaz and its various generic formulations. This is not a situation that Yaz can long ignore.
Another pharmaceutical giant, Glaxo Smith Kline, has set aside billions of dollars to deal with its associated lawsuits, and the makers of Yaz are sure to have their eyes on the mood of public opinion as touching on medical manufacturers.
---
